There are strong genetic components to cardiorespiratory fitness and its
response to exercise training. It would be useful to understand the
differences in the genomic profile of highly trained endurance athletes of
world class caliber and sedentary controls. An international consortium
(GAMES) was established in order to compare elite endurance athletes and
ethnicity-matched controls in a case-control study design. Genome-wide
association studies were undertaken on two cohorts of elite endurance athletes
and controls (GENATHLETE and Japanese endurance runners), from which a panel
of 45 promising markers was identified. These markers were tested for
replication in seven additional cohorts of endurance athletes and controls:
from Australia, Ethiopia, Japan, Kenya, Poland, Russia and Spain. The study is
based on a total of 1520 endurance athletes (835 who took part in endurance
events in World Championships and/or Olympic Games) and 2760 controls. We
hypothesized that world-class athletes are likely to be characterized by an
even higher concentration of endurance performance alleles and we performed
separate analyses on this subsample. The meta-analysis of all available
studies revealed one statistically significant marker (rs558129 at GALNTL6
locus, p = 0.0002), even after correcting for multiple testing. As shown by
the low heterogeneity index (I2 = 0), all eight cohorts showed the same
direction of association with rs558129, even though p-values varied across the
individual studies. In summary, this study did not identify a panel of genomic
variants common to these elite endurance athlete groups. Since GAMES was
underpowered to identify alleles with small effect sizes, some of the
suggestive leads identified should be explored in expanded comparisons of
world-class endurance athletes and sedentary controls and in tightly
controlled exercise training studies. Such studies have the potential to
illuminate the biology not only of world class endurance performance but also
of compromised cardiac functions and cardiometabolic diseases